Before you sell to, join or invest in Mivax Therapeutics, Inc.
MentionFox check on Mivax Therapeutics, Inc.: only 2 sources on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/mivax-therapeutics-inc-form-d-25000001
Check Mivax Therapeutics, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Mivax Therapeutics, Inc.?
Based on the records MentionFox holds for this company. No flag is not a clearance.
Mivax Therapeutics, Inc. filed an amended Form D with the Securities and Exchange Commission on 2025-05-01.
Mivax Therapeutics, Inc. filed an amended Form D notice of an exempt securities offering with the SEC on May 1, 2025. The filing reports $203K sold. Its industry group is Biotechnology. It names Viraj Deshpande (President and Secretary), Pragyesh Dhungel (Chief Executive Officer and Treasurer) (SEC Form D/A, May 1, 2025).
Is this your company?
Sell to companies like Mivax Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-05-01 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Mivax Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Mivax Therapeutics, Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in May 2025, largest first.
Get an email when Mivax Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Mivax Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Mivax Therapeutics, Inc. →Get the full cited report on Mivax Therapeutics, Inc.
What the filing shows about Mivax Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Mivax Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Mivax Therapeutics, Inc.'s address as 701 China Basin St, Apt 605, San Francisco, CA 94158.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Mivax Therapeutics, Inc. →
Amended on 2026-01-23: the offering size changed from indefinite to $500,000; the amount sold changed from $107,500 to $202,500; the number of investors changed from 15 to 21. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Mivax Therapeutics, Inc. See pricing
Mivax Therapeutics, Inc. is a registered filer with the SEC (CIK 2066303) and has filed since 2025-05-01. 4 filings are on record, the latest on 2026-01-23.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Mivax Therapeutics, Inc.'s Form D of 2025-05-01 names Viraj Deshpande and Pragyesh Dhungel as its officers, directors or promoters.
Its new offerings report $108K sold across 1 offering, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
On the filing as: Executive Officer.
Viraj Deshpande is named as President and Secretary on the Form D that Mivax Therapeutics, Inc. filed with the SEC on 1 May 2025, one of 2 people that filing names.
On the filing as: Executive Officer.
Pragyesh Dhungel is named as Chief Executive Officer and Treasurer on the Form D that Mivax Therapeutics, Inc. filed with the SEC on 1 May 2025, one of 2 people that filing names.
2 people named on the filing — 2 holding an executive role.
Named as of the 2025-05-01 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Mivax Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Mivax Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Mivax Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Mivax Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Mivax Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Mivax Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/mivax-therapeutics-inc-form-d-25000001